Synthesis and antihypertensive action of new Imidazo[1,2-a]pyridine derivatives, non peptidic Angiotensin II receptor antagonists

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 11, Issue 2, 2011, Pages 87-96

  Laneri, Sonia ^a   Di Ronza, Cristina ^b   Bernardi, Antonietta ^a   Ostacolo, Carmine ^a   Sacchi, Antonia ^a   Cervone, Carmela ^b   D'Amico, Michele ^b   Di Filippo, Clara ^b   Trincavelli, Maria Letizia ^c   Panighini, Anna ^c   Martini, Claudia ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Antihypertensive in vivo and in vitro activity; Imidazo 1,2 a pyridine; Non Peptidic Angiotensin II Receptor Antagonists; Synthesis and Antihypertensive Action of New Imidazo 1,2 a pyridine Derivatives

Indexed keywords

2 (4 IMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYLCARBAMOYL BENZOIC ACID; 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; 2 (4' IMIDAZO[1,2 A]PYRIDIN 2' YL)PHENYLCARBAMOYL BENZOIC ACID SODIUM CHLORIDE DERIVATIVE; 2 ([[4 (5 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYL]AMINO]CARBONYL)BENZOIC ACID; 2 ([[4 (6 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYL]AMINO]CARBONYL)BENZOIC ACID; 2 ([[4 (6,8 DIMETHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYL]AMINO]CARBONYL)BENZOIC ACID; 2 ([[4 (7 CHLOROIMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYL]AMINO]CARBONYL)BENZOIC ACID; 2 ([[4 (7 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYL]AMINO]CARBONYL)BENZOIC ACID; 2 ([[4 (8 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)PHENYL]AMINO]CARBONYL)BENZOIC ACID; 4 (5 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)ANILINE; 4 (5,7 DIMETHYL IMIDAZO[1,2 A]PYRIDIN 2 YL)ANILINE; 4 (6 CHLORO IMIDAZO[1,2 A]PYRIDIN 2 YL)ANILINE; 4 (6 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)ANILINE; 4 (7 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)ANILINE; 4 (8 METHYLIMIDAZO[1,2 A]PYRIDIN 2 YL)ANILINE; 4 IMIDAZO[1,2 A]PYRIDIN 2 YLANILINE; 5 METHYL 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; 5,7 DIMETHYL 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; 6 CHLORO 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; 6 METHYL 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; 7 METHYL 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; 8 METHYL 2 (4 NITROPHENYL)IMIDAZO[1,2 A]PYRIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; LOSARTAN; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; CHEMICAL STRUCTURE; HUMAN; SYNTHESIS;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; HUMANS; MODELS, MOLECULAR;

EID: 83455247329     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152911798347016     Document Type: Article

References (18)

1. De Gasparo, M.; Catt, K.J.; Inagami, T.; Wright, J.W.; Unger, T. International Union of Pharmacology. XXIII. The Angiotensin II Receptors. Pharmacol. Rev., 2000, 52, 415-472.
2. Lamanna, C.; Catalano, A.; Carocci, A.; Di Mola, A.; Franchini, C.; Tortorella, V.; Vanderheyden, P.M.; Sinicropi, M.S.; Watson, K.A.; Sciabola, S. AT1 receptor ligands: virtual-screeningbased design with TOPP descriptors, synthesis, and biological evaluation of pyrrolidine derivatives. Chem. Med. Chem., 2007, 2(9), 1298-310.
3. Wexter, R.R.; Greenlee, W.J.; Irvin, J.D.; Goldberg, M.R.; Prendergast, K.; Smith, R.D.; Timmermans, P.B. Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J. Med. Chem., 1996, 39, 625-656.
4. Schmidt, B.; Schieffer, B. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. J. Med. Chem., 2003, 46, 2261-2270.
5. Matsuda, A.; Nakajima, J.Y.; Azumat, A.; Tanaka, M.; Sasaki, T. Potent Orally Active Imidazo[4,5-b]pyridine-Based Angiotensin II Receptor Antagonists. J. Med. Chem., 1991, 34, 2919-2922.
6. Walsh, T. F; Fitch, K.J.; MacCoss, M.; Chang, R.S.L.; Kivlighn, S.D.; Lotti, V.J.; Siegl, P.K.S.; Patchen, A.A.; Greenlee, W.J. Synthesis of new Imidazo[1,2-b]Pyridazine Isosteres of potent Imidazo[4,5-b]Pyridine angiotensin II antagonists. Bioorg. Med. Chem. Lett., 1994, 4(1), 219-222.
7. Venkatesan, A.M.; Levin, J.I.; Baker, J.S.; Ghan, P.S.; Bailey, T.; Coupet, J. Substituted 4H-Pyrido[l,2-a]Pyrimidin-4-one angiotensin II receptor antagonists. Bioorg. Med. Chem. Lett., 1994, 4(1), 183-188.
8. Kim, D.; Mantlo, N.B.; Chang, R.S.; Kivlighn, S. D.; Greenlee, W.J. Evaluation of Heterocyclic Acid Equivalents as Tetrazole Replacements in Imidazopyridine-Based Nonpeptide Angiotensin II Receptor Antagonists. Bioorg. Med. Chem. Lett., 1994, 4(1), 41-44.
9. Mantlo, N.B.; Chakravarty, P.K.; Ondeyka, D.L.; Siegl, P.K.S.; Chang, R.S.; Lotti, V.J.; Faust, K.A.; Chen, T.; Schorn, T.W.; Sweet, C.S.; Emmert, S.E.; Patchett, A.A.; Greenlee, W.J. Potent, Orally Active Imidazo[4,5-b]pyridine-Based Angiotensin II Receptor Antagonists. J. Med. Chem., 1991, 34, 2919-2922.
10. Chakravarty, P.K.; Naylor, E.M.; Chen, A.; Chang, R. S. L.; Chen, T.; Faust, K.A.; Lotti, V.J.; Kivlighn, S.D.; Gable, R.A.; Zingaro, G.J.; Schorn, T.W.; Schaffer, L.W.; Broten, T.P.; Sieg, P.K.S.; Patchett, A.A.; Greenlee, W.J. A Highly Potent Orally Active Imidazo[4,5-b]pyridine Biphenyl Acylsulfonamide (MK-996; L-159,282): A New AT1-Selective Angiotensin II Receptor Antagonist. J. Med. Chem., 1994, 37(24), 4068-4072.
11. Cappelli, A.; Pericot Mohr, G.; Giuliani, G.; Galeazzi, S.; Anzini, M.; Mennuni, L.; Ferrari, F.; Makovec, F.; Kleinrath, E.M.; Langer, T.; Valoti, M.; Giorgi, G.; Vomero, S. Further Studies on Imidazo[4,5-b]pyridine AT1 Angiotensin II Receptor Antagonists. Effects of the Transformation of the 4-Phenylquinoline Backbone into 4-Phenylisoquinolinone or 1-Phenylindene Scaffolds. J. Med. Chem., 2006, 49, 6451-6464.
12. Cappelli, A.; Pericot Mohr, G.; Gallelli, A.; Rizzo, M.; Anzini, M.; Vomero, S.; Mennuni, L.; Ferrari, F;. Makovec, F.; Menziani, M.C.; De Benedetti, P.G.; Giorgi, G. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure. J. Med. Chem., 2004, 47, 2574-2586.
13. D'Amico, M.; Dashwood, M.R.; Warner, T.D. Endothelin-1 and the periaqueductal gray area of the rat: an autoradiographic and functional pharmacological study. Br J Pharmacol., 1996, 118, 21-26.
14. Sacchi, A.; Laneri, S.; Arena, F.; Abignente, E.; Gallitelli, M.; D'Amico, M.; Filippelli, W.; Rossi, F. Research on heterocyclic compounds, XLI. 2-Phenylimidazo[1,2-b]pyridazine-3-acetic derivatives: synthesis and anti-inflammatory activity. Eur J Med Chem., 1999, 34(11), 1003-1008.
15. Abignente, E.; de Caprariis, P.; Fattorusso, E.; Mayol, L. Research on Heterocyclic Compounds, XXIII. Phenyl Derivatives of Fused Imidazole Systems. J. Heterocyclic Chem., 1989, 26, 1875-1880.
16. Timmermans, P.B.; Wong, P.C.; Chiu, A.T.; Herblin, W.F.; Benfield, P.; Carini, D.J.; Lee, R.J.; Wexler, R.R.; Saye, J.A.; Smith, R.D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 1993, 157, 205-251.
17. Cazes, M.; Provost, D.; Versigny, A.; Cloarec, A. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist. Eur. J. Pharmacol., 1995, 284, 157-170.
18. Willemsen, J.M.; Rabelink, T.J.; Boer, P.; Gaillard, C.A. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment. J. Hum. Hypertens., 2004, 18(12), 857-63.